Original Research
Published on 05 Jun 2015
Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2015.00290
- 7,153 views
- 14 citations
